Search research articles
Contact Us
Filters
Showing results (261-270 of 312) with videos related to
Page
of 32
Sort By:
The Journal of Antimicrobial Chemotherapy
|
December 26, 2001
An extended interval dosing method for gentamicin in neonates
M D Stickland, C M Kirkpatrick, E J Begg, et al.
The Journal of Antimicrobial Chemotherapy
|
September 3, 2002
Free and total cefazolin plasma and interstitial fluid concentrations at steady state during continuous infusion
Grant W Howard, Evan J Begg, Stephen T Chambers, et al.
Veterinary Research
|
June 19, 2017
Variation in susceptibility of different breeds of sheep to Mycobacterium avium subspecies paratuberculosis following experimental inoculation
D J Begg, A C Purdie, K de Silva, et al.
Pathogens and Disease
|
May 3, 2018
Integrated vaccine screening system: using cellular functional capacity in vitro to assess genuine vaccine protectiveness in ruminants
Hannah B Pooley, Karren M Plain, Auriol C Purdie, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 1, 1989
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment
E J Begg, R R Bailey, K L Lynn, et al.
Therapeutic Drug Monitoring
|
June 20, 2014
Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin
Sabine M Plajer, Paul K L Chin, Jane W A Vella-Brincat, et al.
British Journal of Clinical Pharmacology
|
January 17, 2007
Protein binding of cefazolin is saturable in vivo both between and within patients
Jane W A Vella-Brincat, Evan J Begg, Carl M J Kirkpatrick, et al.
The Journal of Antimicrobial Chemotherapy
|
March 21, 2009
Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates
Evan J Begg, Jane W A Vella-Brincat, Barbara Robertshawe, et al.
Therapeutic Drug Monitoring
|
December 5, 2013
Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?
Pamela J Buffery, Kirstie M Allen, Paul K L Chin, et al.
Veterinary Microbiology
|
May 21, 2018
Immunopathological changes and apparent recovery from infection revealed in cattle in an experimental model of Johne's disease using a lyophilised culture of Mycobacterium avium subspecies paratuberculosis
Douglas J Begg, Karren M Plain, Kumudika de Silva, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 312) with videos related to
Sort By:
Page
of 32
The Journal of Antimicrobial Chemotherapy
|
December 26, 2001
An extended interval dosing method for gentamicin in neonates
M D Stickland, C M Kirkpatrick, E J Begg, et al.
The Journal of Antimicrobial Chemotherapy
|
September 3, 2002
Free and total cefazolin plasma and interstitial fluid concentrations at steady state during continuous infusion
Grant W Howard, Evan J Begg, Stephen T Chambers, et al.
Veterinary Research
|
June 19, 2017
Variation in susceptibility of different breeds of sheep to Mycobacterium avium subspecies paratuberculosis following experimental inoculation
D J Begg, A C Purdie, K de Silva, et al.
Pathogens and Disease
|
May 3, 2018
Integrated vaccine screening system: using cellular functional capacity in vitro to assess genuine vaccine protectiveness in ruminants
Hannah B Pooley, Karren M Plain, Auriol C Purdie, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 1, 1989
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment
E J Begg, R R Bailey, K L Lynn, et al.
Therapeutic Drug Monitoring
|
June 20, 2014
Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin
Sabine M Plajer, Paul K L Chin, Jane W A Vella-Brincat, et al.
British Journal of Clinical Pharmacology
|
January 17, 2007
Protein binding of cefazolin is saturable in vivo both between and within patients
Jane W A Vella-Brincat, Evan J Begg, Carl M J Kirkpatrick, et al.
The Journal of Antimicrobial Chemotherapy
|
March 21, 2009
Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates
Evan J Begg, Jane W A Vella-Brincat, Barbara Robertshawe, et al.
Therapeutic Drug Monitoring
|
December 5, 2013
Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?
Pamela J Buffery, Kirstie M Allen, Paul K L Chin, et al.
Veterinary Microbiology
|
May 21, 2018
Immunopathological changes and apparent recovery from infection revealed in cattle in an experimental model of Johne's disease using a lyophilised culture of Mycobacterium avium subspecies paratuberculosis
Douglas J Begg, Karren M Plain, Kumudika de Silva, et al.
Page
of 32